You just read:

Statement from Acting FDA Commissioner Ned Sharpless, M.D., on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs

News provided by

U.S. Food and Drug Administration

Jun 18, 2019, 14:22 ET